Latest news

Today, 9:02 AM

On Friday, 497 companies set new 52-week lows.

AADI

1 minute read

HC Wainwright & Co. Reiterates Buy on aTyr Pharma, Maintains $35 Price Target

Today, 9:02 AM

HC Wainwright & Co. analyst Joseph Pantginis reiterates aTyr Pharma (NASDAQ:LIFE) with a Buy and maintains $35 price target.

10 minute read

Earnings

Earnings Scheduled For March 9, 2023

Today, 9:02 AM

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is expected to report earnings for its fourth quarter.

ACHR

1 minute read

Roth MKM Reinstates Buy on aTyr Pharma, Announces $9 Price Target

Today, 9:02 AM

Roth MKM analyst Kumaraguru Raja reinstates aTyr Pharma (NASDAQ:LIFE) with a Buy and announces $9 price target.

1 minute read

Atyr Pharma’s Efzofitimod Has Received FDA For Systemic Sclerosis (SSc) And Fast Track Designation For SSc-Associated Interstitial Lung Disease (SSc-ILD); Proof-of-concept Study In SSc-ILD Expected To Begin In 2023

Today, 9:02 AM

The Phase 2 study is expected to be a randomized, double-blind, placebo-controlled, proof-of-concept study to evaluate the efficacy, safety and tolerability of efzofitimod in patients with SSc-ILD. This is expected to be

1 minute read

HC Wainwright & Co. Reiterates Buy on aTyr Pharma, Maintains $35 Price Target

Today, 9:02 AM

HC Wainwright & Co. analyst Joseph Pantginis reiterates aTyr Pharma (NASDAQ:LIFE) with a Buy and maintains $35 price target.

10 minute read

News
Options

Stocks That Hit 52-Week Lows On Tuesday

Today, 9:02 AM

During Tuesday's trading, 160 companies set new 52-week lows.

ABSI

5 minute read

Options

Stocks That Hit 52-Week Lows On Friday

Today, 9:02 AM

On Friday, 64 companies achieved new lows for the year.

ADES

1 minute read

aTyr Pharma Q3 EPS $(0.46), Inline

Today, 9:02 AM

aTyr Pharma (NASDAQ:LIFE) reported quarterly losses of $(0.46) per share which met the analyst consensus estimate. This is a 9.52 percent decrease over losses of $(0.42) per share from the same period last year.